Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 | Garg PushkalEVP Chief R&D |  ALNYALNYLAM PHARMACEUTICALS, INC.Open-market sale | SELL | $15K 42 sh | Jan 14, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $1,117 3 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Snow Colton MatthewSVP, Chief Commercial Officer |  SNCYSun Country Airlines Holdings, Inc.Open-market sale | SELL | $13K 759 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 |  Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $1.62M 14.6K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $28K 76 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $2.49M 22.6K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Mangione Christopher MichaelChief Acct. Off. & VP, Finance | SNCYSun Country Airlines Holdings, Inc. Open-market sale | SELL | $4,489 256 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $32K 87 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $31K 85 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $13K 34 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $49K 135 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $745 2 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Neale Erin RoseSVP, Chief Legal Officer | SNCYSun Country Airlines Holdings, Inc. Open-market sale | SELL | $40K 2,257 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $35K 98 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $44K 123 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $10K 27 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $5,667 15 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $18K 50 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $34K 92 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 41 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $14K 39 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $2,235 6 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 41 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $6,676 18 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $26K 73 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $35K 98 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $14K 39 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $34K 92 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $9,361 25 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $27K 76 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $387K 4,240 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $28K 78 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $7,137 19 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 41 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $18K 50 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $467K 5,182 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 40 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $25K 72 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $459K 1,259 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $279K 778 sh | Jan 14, 2026 traded Jan 12, 2026 |